Back
Inhibrx Vs. Seres Therapeutics Industry Stock Comparison
Buy
61
INBX
Inhibrx
Last Price:
34.32
Seasonality Move:
22.62%
Sell
10
MCRB
Seres Therapeutics
Last Price:
0.56
Seasonality Move:
-9.46%
Buy
61
Inhibrx (INBX)
is a Buy
Is Inhibrx a Buy, Sell or Hold?
- The current Inhibrx [INBX] share price is $34.34. The Score for INBX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
10
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.56. The Score for MCRB is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
INBX Stock Price Chart
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing slight selling pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 35.31 | Sell |
| Chaikin Money Flow: | -66097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.68 - 35.06) | Sell |
| Bollinger Bands (100): | (29.17 - 38.71) | Buy |
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 24.42 | Sell |
| Chaikin Money Flow: | -1455884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.65 - 0.79) | Sell |
| Bollinger Bands (100): | (0.81 - 1.25) | Sell |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.73 | Sell |
| 20-day SMA: | 34.84 | Sell |
| 50-day SMA: | 35.9 | Sell |
| 200-day SMA: | 26.81 | Buy |
| 8-day EMA: | 34.64 | Sell |
| 20-day EMA: | 34.89 | Sell |
| 50-day EMA: | 34.94 | Sell |
| 200-day EMA: | 29.59 | Buy |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.63 | Sell |
| 20-day SMA: | 0.71 | Sell |
| 50-day SMA: | 0.88 | Sell |
| 200-day SMA: | 1.95 | Sell |
| 8-day EMA: | 0.63 | Sell |
| 20-day EMA: | 0.7 | Sell |
| 50-day EMA: | 0.85 | Sell |
| 200-day EMA: | 1.97 | Sell |
Inhibrx Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $0.10 per share.
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.22 per share, and an increase next year of $0.30 per share.
Inhibrx Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Seres Therapeutics Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||